Human RANK / TNFRSF11A Protein, Mouse IgG2a Fc Tag, low endotoxin (MALS verified)
分子別名(Synonym)
CD265,FEO,LOH18CR1,ODFR,OFE,OPTB7,OSTS,PDB2,RANK,TNFRSF11A,TRANCER,CD265 antigen,ODFROSTS,RANKLOH18CR1,NFKB activator
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human RANK Protein, Mouse IgG2a Fc Tag (RAK-H5251) is expressed from human 293 cells (HEK293). It contains AA Ile 30 - Pro 212 (Accession # Q9Y6Q6-1).
Predicted N-terminus: Ile 30
蛋白結(jié)構(gòu)(Molecular Characterization)
![1.jpg 1.jpg](/SupplyImg1/2025-02-08/6387461874940799145110889.jpg)
This protein carries a mouse IgG2a Fc tag at the C-terminus.
The protein has a calculated MW of 47.2 kDa. The protein migrates as 50-55 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
![2.jpg 2.jpg](/SupplyImg1/2025-02-08/6387461875793248023404088.jpg)
![3.jpg 3.jpg](/SupplyImg1/2025-02-08/6387461876116424389587865.jpg)
背景(Background)
RANK/TNFRSF11A是腫瘤壞死因子受體家族的成員。RANK/TNFRSF11A在其細(xì)胞外四個(gè)富含半胱氨酸的重復(fù)序列中與TNFR家族的其他成員具有顯著的氨基酸同源性。小鼠的功能基因組學(xué)表明,RANKL(TNFSF11)是TNF配體超家族的成員,RANK(TNFRSF11a)是RANKL的同源TNFR家族受體,對(duì)體內(nèi)破骨細(xì)胞生成至關(guān)重要。由成骨細(xì)胞譜系的骨基質(zhì)細(xì)胞表達(dá)的RANKL和由造血髓系譜系的破骨細(xì)胞前體表達(dá)的RANK之間的功能相互作用是破骨細(xì)胞分化、存活和激活所必需的。
關(guān)鍵字: RANK;RANK蛋白;RANK重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。